Monday, September 14, 2026

Trump’s Pressure on South Korea: Will They Send Troops to Hormuz or Arm Ukraine?

Trump hints at deploying troops to Korea while signaling military support for Ukraine, showcasing U.S. strategic interests.

What to Expect from North Korea’s 9th Party Congress: Major Economic Developments Revealed

North Korea's Rodong Sinmun reports on construction achievements ahead of the 9th Party Congress, signaling an upcoming propaganda campaign.

North Korea’s iPhone Lookalike Is Watching You

North Korea's Jindallae smartphones gain popularity with advanced features and built-in censorship, reflecting state control and surveillance.

Tag: Onconic Therapeutics

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Onconic Therapeutics Licenses GERD Drug Zaqubo to Indonesia’s Dexa Medica

Onconic Therapeutics partners with Dexa Medica to commercialize GERD treatment Zaqubo in Indonesia, enhancing its global expansion strategy.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Your Guide to Jaqbo: The New GERD Treatment Shaping the Future of Chronic Care

Onconic Therapeutics begins a Phase 3 trial for Jaqbo, aiming to expand GERD treatment options and enhance long-term management strategies.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.